These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8539879)
1. Comparison between methylprednisolone and OKT3 treatment for the first acute rejection episode in combined kidney and pancreas transplant recipients. el-Ghoroury M; Hariharan S; Munda R; Demmy AM; Schroeder TJ; Alexander JW; First MR Transplant Proc; 1995 Dec; 27(6):3133-4. PubMed ID: 8539879 [No Abstract] [Full Text] [Related]
2. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival. Hariharan S; Alexander JW; Schroeder TJ; First MR Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775 [TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients. Kumano K; Irie A; Mashimo S; Endo T; Koshiba K Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691 [No Abstract] [Full Text] [Related]
4. OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation. Meijer RT; Keur I; Surachno S; ten Berge IJ; Schellekens PT Transplant Proc; 2001 May; 33(3):2196-7. PubMed ID: 11377501 [No Abstract] [Full Text] [Related]
5. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study. Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824 [No Abstract] [Full Text] [Related]
6. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related]
7. Long-term results of OKT3-treated renal transplant recipients. Tanabe K; Takahashi K; Sonda K; Tokumoto T; Koga S; Nakazawa H; Goya N; Yagisawa T; Fuchinoue S; Kawai T; Toma H; Ota K Transplant Proc; 1996 Jun; 28(3):1350-1. PubMed ID: 8658689 [No Abstract] [Full Text] [Related]
9. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function. Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289 [No Abstract] [Full Text] [Related]
10. Treatment of renal allograft acute rejection with methylprednisolone: effect of fixed dose versus dose per body mass index. Douzdjian V; Rice JC; Gugliuzza KK; Fisch JC; Carson RW Clin Transplant; 1996 Jun; 10(3):310-5. PubMed ID: 8826672 [TBL] [Abstract][Full Text] [Related]
11. Management of acute rejection of kidney allograft. Yu LX; Jia YB; Zhang Y Di Yi Jun Yi Da Xue Xue Bao; 2002 Aug; 22(8):752-4. PubMed ID: 12376272 [TBL] [Abstract][Full Text] [Related]
13. Reduction of the initial febrile response to OKT3 with indomethacin. First MR; Schroeder TJ; Hariharan S; Weiskittel P Transplant Proc; 1993 Apr; 25(2 Suppl 1):52-4. PubMed ID: 8465426 [No Abstract] [Full Text] [Related]
14. Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients. Piatosa B; Grenda R; Prokurat S Transplant Proc; 1993 Aug; 25(4):2574. PubMed ID: 8356675 [No Abstract] [Full Text] [Related]
15. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts. Alamartine E; Bellakoul R; Berthoux F Transplant Proc; 1994 Feb; 26(1):273-4. PubMed ID: 8108975 [No Abstract] [Full Text] [Related]
16. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center. Inui M; Tanabe K; Ishikawa N; Tokumoto T; Harano M; Otsubo S; Suzuki K; Goya N; Yagisawa T; Nakazawa H; Fuchinoue S; Toma H Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320 [No Abstract] [Full Text] [Related]
17. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection. Herget S; Heemann U; Friedrich J; Kribben A; Wagner K; Philipp T Clin Nephrol; 1996 May; 45(5):352-4. PubMed ID: 8738671 [TBL] [Abstract][Full Text] [Related]
18. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227 [No Abstract] [Full Text] [Related]
19. Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection. Carvalho MF; Adoni T; Saggioro FP; Soares V Transplant Proc; 1998 Sep; 30(6):2876-7. PubMed ID: 9745607 [No Abstract] [Full Text] [Related]
20. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection. Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406 [No Abstract] [Full Text] [Related] [Next] [New Search]